Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04729114
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2021-01-15
Brief Title:
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Sponsor:
Astellas Pharma Global Development Inc
Organization:
Astellas Pharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| mCSPC |
| Prostate Cancer |
| mCRPC |
Keywords:
| Name | View |
|---|---|
| Propella | View |
| Testosterone | View |
| Testosterone suppression | View |
| metastatic castrate sensitive prostate cancer | View |
| metastatic castrate resistant prostate cancer | View |
| metastatic disease | View |
| prostate cancer | View |
| mCSPC | View |
| mCRPC | View |
| abiraterone | View |
| abiraterone decanoate | View |
| abiraterone acetate | View |
| Phase 12a | View |